App-Quantinova.ai

Key Intestinal Genes Involved in Lipoprotein Metabolism Are Downregulated in Insulin-Resistant Males

Patrick Couture - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Coloboma, ocular, autosomal recessive

N/A

Time Course of Epinephrine Administration During Cardiac Arrest Shows Transient Increase in Aortic Pressure at the Cost of Persistent Decrease in Carotid Flow

Xudong Hu - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Adrenaclick

Health Effects of Northern Contaminants and Alcohol Consumption in a Rodent Model of Human Metabolic and Cardiovascular Diseases

Jin Yan - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypertension

N/A

Leptin Promotes the Osteoblast Differentiation and Mineralization of Primary Cultures of Vascular Smooth Muscle Cells by Regulating GSK-3?

Martin K Butcher - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

N/A

guanidine

Chest Compressions Should Be Performed on Arresting Patients with Left Ventricular Assist Devices (LVAD)

Marcia Stahovich - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

What Is the Optimal Chest Compression Depth During Resuscitation from Out-of-Hospital Cardiac Arrest in Adult Patients?

Siobhan Brown - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Cardiac arrest

N/A

Dalcetrapib-Mediated Modulation of Cholesteryl Ester Transfer Protein Activity Increases HDL-Cholesterol, Apolipoprotein A-I Levels and Cholesterol Efflux Capacity in Chow-Fed Rabbits

David Rhainds - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Dalcetrapib

Factors Associated with Readmission Within 48 Hours to a Cardiac Critical Care Unit

Richard Neal - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

N/A

Assessment of Arrest Procedures, Hospital Care and Functional Survival of Initial VT/VF Arrest Patients Shocked by a Bystander AED vs Patients Shocked by EMS

Siobhan Brown - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

Epinephrine

Granzyme B Releases Vascular Endothelial Growth Factor from Extracellular Matrix Stores and Induces Vascular Permeability in vivo

David J Granville - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

DE-074

Translating Guidelines into Practice: A Survey Study to Assess Healthcare Provider Attitudes, Preferences and Beliefs Regarding Pediatric Fluid Resuscitation Practices

Melissa J Parker - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

N/A

Methadone hydrochloride

Extensive Coronary Artery Atherosclerosis and Myocardial Infarction in SR-BI/LDLR Double Knockout Mice Fed 4 Different Atherogenic Diets

Bernardo L Trigatti - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

cholic acid

Overrepresentation of Familial Hypercholesterolemia-causing Mutations in Patients with Familial Combined Hyperlipidemia

Henian Cao - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Familial combined hyperlipidemia

N/A

Experimental use of a Pediatric Fluid Resuscitation Model: Evaluating Test-retest Reliability and Inter-subject Variability

Frank MH Lee - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Septic shock

N/A

Developing an In Vivo Model of Ventricular Refibrillation

Andrew Ramadeen - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

The Family Study: Assessment of the Risk for Sudden Cardiac Arrest in Family Members of Cardiac Arrest Patients

Theresa Aves - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Structural Heart Disease

N/A

C/EBP ? Mediates Shear Stress-Dependent Downregulation of the Angiotensin Type 1 Receptor

Daniel Rivas - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Angiotensin II

Evaluating the Challenges of Functional Outcomes in Traumatic Brain Injury Research: Timing of Follow-Up, Prognostic Models, and Missing Data

Laurie J. Morrison - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Traumatic brain injury

N/A

Dantrolene Decreases Susceptibility to Refibrillations by Restoring Vf Dependent Cardiac Calcium Handling Dysfunction

Marjan Kusha - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Arrhythmia

Dantrolene Injection

Reevaluating Epinephrine In Out-of-Hospital Cardiac Arrest: A Systematic Review And Meta-analysis

Clifton W. Callaway - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

Epinephrine

Filters

28841 Abstracts